Paradigm Clinical Research announced the opening of a psychedelic research suite in Redding on June 18. The company stated that this move strengthens its capabilities in psychiatric clinical trials and studies evaluating psychedelic-assisted therapies. The new research suite is designed to provide purpose-built environments, specialized training, careful monitoring, and deep respect for participant experience. It will support studies across various indications, including major depressive disorder, treatment-resistant depression, post-traumatic stress disorder, substance use disorders, and anorexia nervosa.